South Korea’s hyaluronic acid (HA) products market is among the fastest-growing globally, driven by a strong demand for aesthetic treatments and a rising focus on therapeutic applications in orthopedics and ophthalmology. The market is projected to surpass USD 429.7 million by 2035 and grow at a CAGR of 4.8% from 2025 to 2035.
The dermal fillers, which are used for wrinkle correction, facial contouring, and skin rejuvenation, are in huge demand among the country's beauty-conscious population. South Korean consumers are very keen on non-invasive cosmetic procedures that deliver effective and natural-looking results. This trend is further boosted by the nation's advanced cosmetic infrastructure, including a high concentration of dermatology clinics and medispas.
The healthcare sector, on its side, is a large contributor, mainly from the usage of HA-based viscosupplements for osteoarthritis treatment. With this older age group and increasing joint disorders, such non-invasive treatments have emerged to become the first choice for pain management and mobility enhancement. Moreover, ophthalmic applications of HA, including cataract surgery and dry eye syndrome treatments, are increasing at a stable rate.
South Korea's strong biotechnology ecosystem supports the development of advanced HA products, with local players focusing on innovations such as tailored fillers and cost-effective solutions for healthcare. The growth in medical tourism and global popularity of K-beauty further strengthen the country's position as a key market for HA products.
| Attributes | Details |
|---|---|
| Projected Sales (2035) | USD 429.7 Million |
| Value-based CAGR (2025 to 2035) | 4.8% |
Explore FMI!
Book a free demo
Rising Trend of HA Dermal Fillers: HA-based fillers are one of the leading portions of the South Korean HA market, given the great emphasis that exists in South Korea on beauty and anti-aging products. Fillers for Asian skin are widely popular in clinics, providing facial symmetry along with a very natural result. Lip augmentation, cheek enhancement, and wrinkle smoothing remain at the top for younger consumers as well as those in their midlife years.
Increased Use of HA in Osteoarthritis Management: The aging population within South Korea alongside the increasing involvement of adults with physical activities further increased the call for HA viscosupplements. Such drugs are proving successful alternatives to operations for the relieving pain while improving joint mobility to patients. Their multi-injection and single dosage formulations are popular across hospitals and clinics, where health care facilities give them out, touting minimally invasive care.
Ophthalmic Applications Technology: HA-based products are now being adopted in South Korea's ophthalmology sector, applied in cataract surgeries, retinal procedures, and dry eye treatments. HA enhances lubrication, biocompatibility, and surgical precision, which makes it irreplaceable. With the disease trend in old age, growth in this segment will also increase.
New Developments in HA Formulations: Local manufacturers and global players in South Korea are at the forefront of developing cutting-edge HA products. Innovations include cross-linked fillers that last longer and fillers optimized for multi-layer injections, catering to the diverse needs of the cosmetic market.
| Industry | Growth Trends |
|---|---|
| Aesthetics | Aesthetics Dermal fillers dominate the HA market as consumers seek non-invasive solutions for facial rejuvenation and anti-aging. |
| Orthopedics | Orthopedics HA viscosupplements are becoming the preferred treatment for osteoarthritis, providing pain relief and mobility improvement without surgery.. |
| Ophthalmology | Ophthalmology HA-based solutions for cataract surgeries and dry eye syndrome drive growth, supported by advancements in surgical precision and outcomes. |
The South Korean HA market is moderately consolidated, with global giants dominating dermal fillers and domestic players excelling in affordable orthopedic and ophthalmic solutions.
Conclusion
The country's beauty culture and well-equipped health care sector make South Korea an attractive destination for HA product companies. In the premium dermal filler market, international companies hold a prominent position, whereas domestic players like Daewoong Pharma and Hugel utilize their regional advantage to come up with novel products and offer more affordable products.
| Vendor Tier | Tier 1 |
|---|---|
| Key Vendors | Allergan, Galderma, LG Chem, Sanofi, Teoxane |
| Market Share (%) | 55% |
| Description | Global leaders dominate the premium HA dermal filler market with advanced formulations and established brands. |
| Vendor Tier | Tier 2 |
|---|---|
| Key Vendors | Hugel, Medytox, Revance |
| Market Share (%) | 35% |
| Description | Domestic players focus on cost-effective, innovative solutions for both aesthetic and therapeutic applications. |
| Vendor Tier | Tier 3 |
|---|---|
| Key Vendors | Contipro, Hyalogic, Shiseido |
| Market Share (%) | 10% |
| Description | Niche players specialize in vegan and cruelty-free HA products, targeting eco-conscious consumers. |
Rising Popularity of Cosmetic Enhancements
The country's beauty-conscious culture, fuelled by social media and K-beauty trends, drives the demand for dermal fillers. These are minimally invasive treatments that provide instant results with minimum recovery time and are popular across various age groups.
Aging Population and Osteoarthritis Prevalence
The aging demographic in South Korea propels the use of HA viscosupplements as a non-surgical treatment for osteoarthritis. The product caters to the increasing requirement for effective pain management and improved mobility.
Innovation in HA-Based Solutions
South Korea’s advanced R&D ecosystem drives the development of cutting-edge HA formulations, such as bioengineered fillers and slow-release viscosupplements, ensuring superior efficacy and patient satisfaction.
High Competition in Aesthetic Markets
HA market is highly competitive in South Korea. In-country players offer cheap alternatives to globally premium brands, thus encroaching their market dominance.
Regulatory Hurdles
Strict regulations of aesthetic and healthcare products delay the new market entry with innovative HA formulations that act as entry barriers to the new entrant.
Price Sensitivity Among Consumers
Despite the high demand of advanced fillers, a relatively high cost prohibits middle-class buyers, especially for areas outside metro areas.
| Date | Jan 2024 |
|---|---|
| Company | Allergan |
| Update | Launched a new range of HA fillers in South Korea with enhanced cross-linking technology for facial rejuvenation. |
| Date | Apr 2024 |
|---|---|
| Company | LG Chem |
| Update | Released a long-lasting viscosupplement specifically targeting knee osteoarthritis in the South Korean market. |
| Date | Jul 2024 |
|---|---|
| Company | Medytox |
| Update | Expanded its portfolio to include bioengineered HA fillers offering superior durability and hydration. |
| Date | Oct 2024 |
|---|---|
| Company | Hugel |
| Update | Introduced vegan-certified HA fillers to meet rising demand for sustainable cosmetic solutions. |
| Date | Dec 2024 |
|---|---|
| Company | Teoxane |
| Update | Partnered with South Korean clinics to offer tailored HA filler solutions for advanced facial contouring treatments. |
South Korea’s HA products market is expected to exceed USD 429.7 billion by 2035, driven by the dual demand for dermal fillers in aesthetic applications and viscosupplements for osteoarthritis management.
Aesthetic treatments will remain the main stream, and dermal fillers and skin boosters will be highly in demand.
It's going to go up substantially within the healthcare context, with many elderly patients interested in osteoarthritis as an effective drugless solution. Expansions from ophthalmic applications will support cataracts and dry-eye syndromes because of new development in biocompatible formulations. Through affordability and understanding of HA-specific products for consumers in Asia, domestic manufacturers shall increase their shares in the world arena.
The market is expected to grow at a CAGR of 4.8% from 2025 to 2035.
The market is expected to reach USD 429.7 million.
Dermal fillers and viscosupplements for osteoarthritis lead the market, driven by rising consumer demand and an aging population.
Global leaders include Allergan, Galderma, and Teoxane, while domestic innovators such as Hugel and Medytox hold significant market shares.
Epidemic Keratoconjunctivitis Treatment Market Overview – Growth, Trends & Forecast 2025 to 2035
Eosinophilia Therapeutics Market Insights – Trends & Forecast 2025 to 2035
Endometrial Ablation Market Analysis - Size, Share & Forecast 2025 to 2035
Endotracheal Tube Market - Growth & Demand Outlook 2025 to 2035
Encephalitis Treatment Market - Growth & Future Trends 2025 to 2035
Edward’s Syndrome Treatment Market – Growth & Future Prospects 2025 to 2035
South Korea Hyaluronic Acid Products Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
